España

COVID-19: MENARINI, NEW MADE IN ITALY REAGENT TO ISOLATE VIRAL RNA

Menarini Diagnostics, a company of the Menarini Group, launches the Leasy Kit.

Menarini Diagnostics acquires EOS Preanalytics and Point Of Care company assets

FLORENCE, January 15th, 2021 - Menarini Diagnostics, a company of the Menarini Group

A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION.

September 3rd, 2020 – Firenze, Italy and Bad Homburg, Germany

German Minister of Health Jens Spahn receives briefing on Menarini Diagnostics fast and reliable COVID VitaPCR® POC instrument.

On August 20th the German Minister of Health, Jens Spahn visited the Red Cross Hospital of Mölln-Ratzeburg. 

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

1234

MSDS

Safety sheets of the reagent.

READ MORE »